pargyline has been researched along with Dystonia in 1 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Dystonia: An attitude or posture due to the co-contraction of agonists and antagonist muscles in one region of the body. It most often affects the large axial muscles of the trunk and limb girdles. Conditions which feature persistent or recurrent episodes of dystonia as a primary manifestation of disease are referred to as DYSTONIC DISORDERS. (Adams et al., Principles of Neurology, 6th ed, p77)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heintz, R | 1 |
| Casey, DE | 1 |
1 other study available for pargyline and Dystonia
| Article | Year |
|---|---|
Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.
Topics: Animals; Basal Ganglia Diseases; Cebus; Corpus Striatum; Dopamine; Dystonia; Female; Haloperidol; Ma | 1987 |